Literature DB >> 24629997

Melanoma depth in patients with an established dermatologist.

Michelle Y Cheng1, Jacqueline F Moreau1, Sean T McGuire2, Jonhan Ho3, Laura K Ferris4.   

Abstract

BACKGROUND: The impact of having an established dermatologist on melanoma depth at diagnosis is incompletely understood.
OBJECTIVE: We sought to determine whether having had a previous dermatologic examination (an established dermatologist), the recency of the last examination, and the wait time for the dermatology appointment are associated with melanoma invasiveness and depth.
METHODS: This was a retrospective cross-sectional study of 388 patients with primary melanoma at an academic dermatology department.
RESULTS: Patients with an established dermatologist were more likely than patients without an established dermatologist to be given a diagnosis of melanoma in situ (103/162 [63.6%] vs 69/155 [44.5%], P = .001) and to have thinner invasive melanoma (0.48 [0.30-0.71] mm vs 0.61 [0.40-1.10] mm, respectively, P = .003). These trends were observed for patients with self-detected, but not dermatologist-detected, melanoma. Patient-detected melanomas made up 184/361 (51.0%) of all melanomas, 83/199 (41.7%) of in situ melanomas, and 101/162 (62.4%) invasive melanomas. Self-detected melanomas were in situ in 36 of 61 (59.0%) patients with an established dermatologist versus 40 of 108 (37.0%) patients without an established dermatologist, P = .006. Neither time from last dermatologic examination nor wait time for an appointment was associated with melanoma invasiveness or depth. LIMITATIONS: Data are retrospective and from 1 large academic health care system.
CONCLUSION: Education obtained at the dermatology appointment may improve early self-detection of melanoma, and having an established dermatologist may facilitate earlier evaluation of concerning lesions.
Copyright © 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  dermatology; education; melanoma; prevention; public health; skin cancer

Mesh:

Year:  2014        PMID: 24629997     DOI: 10.1016/j.jaad.2013.10.060

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  The role of spatially-derived access-to-care characteristics in melanoma prevention and control in Los Angeles county.

Authors:  Loraine A Escobedo; Ashley Crew; Ariana Eginli; David Peng; Michael R Cousineau; Myles Cockburn
Journal:  Health Place       Date:  2017-04-06       Impact factor: 4.078

2.  Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients.

Authors:  Alyce Anderson; Laura K Ferris; Benjamin Click; Claudia Ramos-Rivers; Ioannis E Koutroubakis; Jana G Hashash; Michael Dunn; Arthur Barrie; Marc Schwartz; Miguel Regueiro; David G Binion
Journal:  Dig Dis Sci       Date:  2018-04-30       Impact factor: 3.199

3.  "Better do not touch" and other superstitions concerning melanoma: the cross-sectional web-based survey.

Authors:  Maksymilian Gajda; Grażyna Kamińska-Winciorek; Jerzy Wydmański; Andrzej Tukiendorf
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

4.  Differences in the diagnosis of primary cutaneous melanoma in the public and private healthcare systems in Joinville, Santa Catarina State, Brazil.

Authors:  Raquel Bissacotti Steglich; Silvana Cardoso; Maria Helena da Costa Naumann Gaertner; Karina Munhoz de Paula Alves Coelho; Tania Ferreira Cestari; Selma Cristina Franco
Journal:  An Bras Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.896

5.  Disparities in access for melanoma screening by region, specialty, and insurance: A cross-sectional audit study.

Authors:  Jose Luis Cortez; Raj P Fadadu; Sailesh Konda; Barbara Grimes; Maria L Wei
Journal:  JAAD Int       Date:  2022-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.